ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VERA vs XNCR // EV/EBITDA & P/E VALUATION

Vera Therapeutics Inc. (Class A) (NASDAQ) VS. Xencor Inc. (NASDAQ) • 15-METRIC TALLY: VERA 1 — XNCR 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VERA VS. XNCR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VERA XNCR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -21.30% -13.70 XNCR /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -10.99% -6.37% -4.62 XNCR /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 13.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.32 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 XNCR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.7 66.2 -13.50 XNCR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.23B $2.22B $15.3M VERA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VERA REV XNCR REV VERA GROSS % XNCR GROSS % VERA FCF XNCR FCF
FY 2025 $883.3M $125.6M — — -$241.7M -$138.3M
FY 2024 $468.1M $110.5M — — -$135.7M -$208.3M
FY 2023 $285.6M $174.6M — — -$92.2M -$77.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VERA // BETA —
XNCR // BETA —